{"id":36955,"date":"2014-08-01T09:12:25","date_gmt":"2014-08-01T13:42:25","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=36955"},"modified":"2014-08-02T05:58:25","modified_gmt":"2014-08-02T10:28:25","slug":"rol-de-los-inhibidores-de-la-fosfodiesterasa-tipo-v-en-el-fenomeno-de-raynaud","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/36955","title":{"rendered":"Rol de los inhibidores de la fosfodiesterasa tipo V en el fen\u00f3meno de Raynaud"},"content":{"rendered":"<p>Presentamos una revisi\u00f3n sobre la acci\u00f3n de los inhibidores del la 5 fosfodiesterasa, En este articulo mencionamos los m\u00e1s conocidos. Recientemente hay trabajos sobre el Udenafil, que pertenece al mismo grupo y tambi\u00e9n muestra acci\u00f3n sobre las arterias digitales en Raynaud.<\/p>\n<p>&nbsp;<\/p>\n[dl url=\u00bbhttp:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2014\/08\/Rol-de-IFD-5-en-Raynaud.pdf\u00bb title=\u00bbDESCARGAR\u00bb desc=\u00bbRol-de-IFD-5-en-Raynaud\u00bb type=\u00bbpdf\u00bb]\n<p>&nbsp;<\/p>\n<p>Quienes tengan interes en este ultimo principio activo pueden consultar la siguiente cita:<\/p>\n<ul>\n<li><em>Eun Young Lee, Jin Kyun Park, Whal Lee.Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary<\/em><\/li>\n<li><em>Raynaud\u2019s phenomenon: a double-blind, randomized, cross-over study .Rheumatology 2014;53:658 664<\/em><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Presentamos una revisi\u00f3n sobre la acci\u00f3n de los inhibidores del la 5 fosfodiesterasa, En este articulo mencionamos los m\u00e1s conocidos. Recientemente hay trabajos sobre el Udenafil, que pertenece al mismo grupo y tambi\u00e9n muestra acci\u00f3n sobre las arterias digitales en Raynaud. &nbsp; [dl url=\u00bbhttp:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2014\/08\/Rol-de-IFD-5-en-Raynaud.pdf\u00bb title=\u00bbDESCARGAR\u00bb desc=\u00bbRol-de-IFD-5-en-Raynaud\u00bb type=\u00bbpdf\u00bb] &nbsp; Quienes tengan interes en este ultimo principio &hellip;<\/p>\n","protected":false},"author":51,"featured_media":36956,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,317],"tags":[],"class_list":["post-36955","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-secciones-de-colaboradores","category-colagenopatia-al-dia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/36955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/51"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=36955"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/36955\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/36956"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=36955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=36955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=36955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}